Junípero Capital
Overview
Junípero Capital is a venture capital firm investing in early-stage technology companies across various sectors. The firm focuses on seed and Series A financing for companies in artificial intelligence and biotechnology, aiming to support innovations that transcend human lifespan. Junípero Capital has invested in companies such as bhb therapeutics, BOPZ nutrition, Chrysea, Lygenesis, and Morphoceuticals, among others.
Investment Focus
- Innovative technology solutions
- Strong founding teams
- Scalable business models
Portfolio Companies
Get the full list of 54,000+ investors
Junípero Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Junípero Capital
What sectors does Junípero Capital invest in?
Junípero Capital invests in Technology, Healthcare, Artificial Intelligence and Biotechnology, and is based in California, United States. Junípero Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Junípero Capital invest at?
Junípero Capital backs companies at Seed, Early Stage and Series A, writing cheques of 1M - 50M.
Which regions does Junípero Capital invest in?
Junípero Capital invests across United States.
What companies has Junípero Capital invested in?
Junípero Capital's portfolio includes Lygenesis, bhb therapeutics, BOPZ nutrition, Chrysea and Morphoceuticals.
Last updated · Source: ConnectSafely investor database
